Back to Peptides
Phase 2Script Required

CJC-1295 for Mild Autoimmune Syndrome

CJC-1295 may help with Mild Autoimmune Syndrome through its GHRH agonist, Ghrelin mimetic mechanisms, potentially supporting muscle growth, fat loss.

About Mild Autoimmune Syndrome

Mild Autoimmune Syndrome affects individuals through various symptoms impacting daily life. Treatment approaches focus on symptom management and improving quality of life.

Common Symptoms

fatigueinflammationpain

Conventional Treatments

  • medication
  • therapy

How CJC-1295 May Help

Studies on CJC-1295 have shown promising results for increased HGH and muscle growth. Legal status in Australia: Script Required.

Mechanisms of Action

GHRH agonist

Potential Benefits

  • increased HGH
  • muscle growth
  • fat loss

Research Status & Legal Information

Research Status

Phase 2

Legal Status (Australia)

Script Required

Medical Disclaimer

This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare practitioner before starting any peptide therapy.

Potential Side Effects

  • injection site reactions
  • flushing
CJC-1295 for Mild Autoimmune Syndrome | Varney Health